PlantPharm cover feature

PlantPharm

98% of vaccines are given with needles. But, we’re changing that!
$68,802 Raised
Ended May 1st
103 Investors

We are a global frontrunner in making oral vaccines a reality. We’ve created a proprietary Platform Technology using organic plants to manufacture Vaccines and Biologic Drugs. We have proven the Platform Technology through several grants from U.S. National Institutes of Health R&D, by a successful double-blind, placebo-controlled human clinical trial, and by endorsement of the U.S. Food and Drug Administration’s authorization of a second clinical trial on our very first vaccine.

Why you may want to invest
  1. New Platform Technology for organic production of pharmaceuticals.

  2. With our Platform, green plants are used to manufacture complex biological drugs.

  3. We have the ability to transform vaccines and certain biologic drugs from needle delivery to oral delivery using plants.

  4. Humanitarian vaccination efforts worldwide are enhanced by being able to administer shelf-stable, oral vaccines without the need for a cold-chain environment and a needle.

  5. With our proprietary Platform we can economically produce pure biologic drugs and vaccines using plants resulting in lower costs of biopharmaceuticals in the future.

Learn more about this company

Company Details

Location
Delavan, WI
Founded
2008
Employees
3

Key Team Members

Cheryl J. Dillner
Secretary and Board Member
Peggy L. Britt
Controller
Richard R Matner
President and Board Member

Financials

Most recent Fiscal Year

Income Statement

Revenue
$0
Cost of Goods Sold
$0
Gross Profit
$0
Taxes
$0
Net Income
53%
-$19,758

Balance Sheet

Total Assets
5%
$54,079
Cash
1%
$50,027
Accounts Receivable
100%
$0
Short Term Debt
100%
$0
Long Term Debt
11%
$191,710

Other popular startups

Get email updates for the latest investment opportunities
Email
Email